Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Standards
|
Atogepant for preventing migraineNICE Guidance, 2024Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
2 |
Material Type: Standards
|
Selinexor with bortezomib and dexamethasone for previously treated multiple myelomaNICE Guidance, 2024Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
3 |
Material Type: Standards
|
Selinexor with dexamethasone for treating relapsed or refractory multiple myeloma after 4 or more treatmentsNICE Guidance, 2024Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
4 |
Material Type: Standards
|
Digital technologies to deliver pulmonary rehabilitation programmes for adults with COPD: early value assessmentNICE Guidance, 2024Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
5 |
Material Type: Standards
|
Ritlecitinib for treating severe alopecia areata in people 12 years and overNICE Guidance, 2024Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
6 |
Material Type: Standards
|
Dupilumab for treating moderate to severe prurigo nodularisNICE Guidance, 2024Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
7 |
Material Type: Standards
|
Talazoparib for treating HER2-negative advanced breast cancer with germline BRCA mutationsNICE Guidance, 2024Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
8 |
Material Type: Standards
|
Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancerNICE Guidance, 2024Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
9 |
Material Type: Standards
|
Epilepsies in children, young people and adultsNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
10 |
Material Type: Standards
|
Cardiovascular disease: risk assessment and reduction, including lipid modificationNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
11 |
Material Type: Standards
|
Velmanase alfa for treating alpha-mannosidosisNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
12 |
Material Type: Standards
|
Secukinumab for treating moderate to severe hidradenitis suppurativaNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
13 |
Material Type: Standards
|
Zanubrutinib for treating chronic lymphocytic leukaemiaNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
14 |
Material Type: Standards
|
Suspected acute respiratory infection in over 16s: assessment at first presentation and initial managementNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
15 |
Material Type: Standards
|
Tirzepatide for treating type 2 diabetesNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
16 |
Material Type: Standards
|
Stroke rehabilitation in adultsNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
17 |
Material Type: Standards
|
Rimegepant for treating migraineNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
18 |
Material Type: Standards
|
Artificial intelligence-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals: early value assessmentNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
19 |
Material Type: Standards
|
KardiaMobile 6L for measuring cardiac QT interval in adults having antipsychotic medicationNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
20 |
Material Type: Standards
|
Pembrolizumab for previously treated endometrial, biliary, colorectal, gastric or small intestine cancer with high microsatellite instability or mismatch repair deficiencyNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |